申请人:Yu Chung-Shan
公开号:US20130217639A1
公开(公告)日:2013-08-22
The present invention provides a compound selected from compound of formula (I), pharmaceutically acceptable salts of compound of formula (I), and pharmaceutically acceptable prodrugs of compound of formula (I),
and a composition comprising the compound of the above and a pharmaceutically acceptable excipient.
The present invention also provides a method for preparing a compound that activates natural killer T cells.
本发明提供了一种选择自公式(I)化合物、公式(I)化合物的药用可接受盐和公式(I)化合物的药用可接受前药的化合物,以及包含上述化合物和药用可接受赋形剂的组合物。本发明还提供了一种用于制备激活自然杀伤T细胞的化合物的方法。